S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NYSE:LLY

Eli Lilly and News Headlines

$206.92
+6.38 (+3.18 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$200.88
Now: $206.92
$207.67
50-Day Range
$186.69
MA: $202.81
$212.72
52-Week Range
$117.06
Now: $206.92
$218.00
Volume3.81 million shs
Average Volume4.54 million shs
Market Capitalization$198.32 billion
P/E Ratio33.81
Dividend Yield1.68%
Beta0.37

Headlines

Eli Lilly and (NYSE LLY) News Headlines Today

Source:
SourceHeadline
Eli Lilly and (NYSE:LLY) Price Target Increased to $235.00 by Analysts at CowenEli Lilly and (NYSE:LLY) Price Target Increased to $235.00 by Analysts at Cowen
marketbeat.com - February 12 at 8:28 AM
Lilly exec resigns after relationship that violated policyLilly exec resigns after relationship that violated policy
marketbeat.com - February 9 at 9:47 AM
3 Recession-Proof Dividend Stocks to Buy Now (LLY)3 Recession-Proof Dividend Stocks to Buy Now (LLY)
marketbeat.com - February 1 at 5:14 PM
Follow Eli Lillys (NYSE:LLY) Lead, and Make a  Big PurchaseFollow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase
marketbeat.com - December 15 at 11:42 AM
How to Invest After a Turbulent 2020 Election (LLY)How to Invest After a Turbulent 2020 Election (LLY)
marketbeat.com - November 23 at 5:51 PM
Amgen (NASDAQ:AMGN) Proves the Value of Diversification (LLY)Amgen (NASDAQ:AMGN) Proves the Value of Diversification (LLY)
marketbeat.com - October 29 at 11:54 AM
Contrasting Eli Lilly and (NYSE:LLY) and Global Blood Therapeutics (NASDAQ:GBT)Contrasting Eli Lilly and (NYSE:LLY) and Global Blood Therapeutics (NASDAQ:GBT)
americanbankingnews.com - March 6 at 12:14 AM
EMA issues advice on Lillys bamlanivimab (LY-CoV555) alone and administered together with etesevimab (LY-CoV016) for the treatment of confirmed COVID-19 in the European UnionEMA issues advice on Lilly's bamlanivimab (LY-CoV555) alone and administered together with etesevimab (LY-CoV016) for the treatment of confirmed COVID-19 in the European Union
finance.yahoo.com - March 5 at 2:28 PM
UPDATE 1-EU regulator advises on use of Lillys COVID-19 antibody cocktailUPDATE 1-EU regulator advises on use of Lilly's COVID-19 antibody cocktail
finance.yahoo.com - March 5 at 2:28 PM
EU regulator advises on use of Lillys COVID-19 antibody cocktailEU regulator advises on use of Lilly's COVID-19 antibody cocktail
finance.yahoo.com - March 5 at 2:28 PM
EMAs Medicinal Committee Backs Eli Lillys COVID-19 Antibody TherapyEMA's Medicinal Committee Backs Eli Lilly's COVID-19 Antibody Therapy
feeds.benzinga.com - March 5 at 1:09 PM
Zoladex Market Report 2021 Growth Factors, Research Methodology With Impact of COIVD-19 and Global Forecast 2025Zoladex Market Report 2021 Growth Factors, Research Methodology With Impact of COIVD-19 and Global Forecast 2025
marketwatch.com - March 5 at 9:27 AM
Eli Lilly Will Unveil Alzheimer’s Drug Data Next Week. What to Watch.Eli Lilly Will Unveil Alzheimer’s Drug Data Next Week. What to Watch.
finance.yahoo.com - March 5 at 9:27 AM
Eli Lilly (LLY) Stock Moves -0.72%: What You Should KnowEli Lilly (LLY) Stock Moves -0.72%: What You Should Know
finance.yahoo.com - March 4 at 7:44 PM
Eli Lillys Tirzepatide Tops Novos Semaglutide In Late-Stage Diabetes StudyEli Lilly's Tirzepatide Tops Novo's Semaglutide In Late-Stage Diabetes Study
feeds.benzinga.com - March 4 at 12:26 PM
Vir Stock Craters On Weak Data For GSK-Partnered Covid TreatmentVir Stock Craters On Weak Data For GSK-Partnered Covid Treatment
finance.yahoo.com - March 3 at 12:45 PM
Eli Lilly and Company (NYSE:LLY) Receives Consensus Rating of "Buy" from BrokeragesEli Lilly and Company (NYSE:LLY) Receives Consensus Rating of "Buy" from Brokerages
americanbankingnews.com - March 3 at 12:26 PM
Why Is Lilly (LLY) Down 2.5% Since Last Earnings Report?Why Is Lilly (LLY) Down 2.5% Since Last Earnings Report?
finance.yahoo.com - February 28 at 2:38 PM
Biden administration buys 100,000 doses of Lilly antibody drugBiden administration buys 100,000 doses of Lilly antibody drug
msn.com - February 26 at 5:30 PM
US government purchases 100K doses of Eli Lilly combination therapy to treat COVID-19US government purchases 100K doses of Eli Lilly combination therapy to treat COVID-19
msn.com - February 26 at 12:29 PM
US Government Calls For Additional Eli Lilly COVID-19 Antibody TherapyUS Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy
benzinga.com - February 26 at 8:34 AM
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
finance.yahoo.com - February 26 at 7:29 AM
Coronavirus Mutations: Why The Battle Against Covid Is Just BeginningCoronavirus Mutations: Why The Battle Against Covid Is Just Beginning
finance.yahoo.com - February 26 at 7:29 AM
Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapyEli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy
finance.yahoo.com - February 26 at 7:29 AM
UPDATE 1-U.S. to buy at least 100,000 doses of Lillys COVID-19 antibody therapyUPDATE 1-U.S. to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy
finance.yahoo.com - February 26 at 7:29 AM
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lillys connected insulin solutionsWelldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions
finance.yahoo.com - February 25 at 9:02 AM
Lilly to Participate in Cowen Health Care ConferenceLilly to Participate in Cowen Health Care Conference
finance.yahoo.com - February 24 at 7:38 PM
Alvogen Pharma US, Inc. -- Moodys affirms Alvogens ratings; outlook revised to negativeAlvogen Pharma US, Inc. -- Moody's affirms Alvogen's ratings; outlook revised to negative
finance.yahoo.com - February 24 at 7:38 PM
Erbitux Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026Erbitux Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026
marketwatch.com - February 23 at 11:07 PM
Big Pharma Short Percentage Is Below Overall MarketBig Pharma Short Percentage Is Below Overall Market
finance.yahoo.com - February 23 at 6:06 PM
Global Endocrinology Drugs Market Top Manufacturers Statistics Reviews till 2031| AbbVie, AstraZeneca, Eli LillyGlobal Endocrinology Drugs Market Top Manufacturers Statistics Reviews till 2031| AbbVie, AstraZeneca, Eli Lilly
marketwatch.com - February 23 at 8:05 AM
Eli Lilly Is Poised for a Pullback Before Renewed Longer-Term GainsEli Lilly Is Poised for a Pullback Before Renewed Longer-Term Gains
finance.yahoo.com - February 23 at 8:05 AM
Eli Lilly CEO: We see a path to have an Alzheimers disease-modifying drugEli Lilly CEO: We see a path to have an Alzheimer's disease-modifying drug
msn.com - February 22 at 8:04 PM
Eli Lilly CEO on Alzheimers drug candidate update, Covid antibody treatmentEli Lilly CEO on Alzheimer's drug candidate update, Covid antibody treatment
cnbc.com - February 22 at 8:04 PM
Eli Lilly and Company Just Recorded A 6.7% EPS Beat: Heres What Analysts Are Forecasting NextEli Lilly and Company Just Recorded A 6.7% EPS Beat: Here's What Analysts Are Forecasting Next
nasdaq.com - February 19 at 12:23 PM
Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 millionEli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 million
msn.com - February 18 at 10:28 AM
Eli lilly to pay up to $960 million for Rigels autoimmune disease therapyEli lilly to pay up to $960 million for Rigel's autoimmune disease therapy
msn.com - February 18 at 10:28 AM
Eli Lillys Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes ShowEli Lilly's Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes Show
finance.yahoo.com - February 17 at 12:32 PM
Vir and GSK Will Collaborate on Flu TherapyVir and GSK Will Collaborate on Flu Therapy
finance.yahoo.com - February 17 at 12:32 PM
Kimberly H. Johnson Elected to Lilly Board of DirectorsKimberly H. Johnson Elected to Lilly Board of Directors
finance.yahoo.com - February 17 at 7:24 AM
Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lillys SURPASS programTirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly's SURPASS program
finance.yahoo.com - February 17 at 7:24 AM
Attention Deficit Hyperactivity Disorder Therapeutics Market Research With Method, Top Companies, Global Development Factors,and Forecast 2026Attention Deficit Hyperactivity Disorder Therapeutics Market Research With Method, Top Companies, Global Development Factors,and Forecast 2026
marketwatch.com - February 16 at 3:20 PM
Global Phenobarbital Market and Ribavirin Market Outlook to 2027 By Upcoming Trends and Challenges, Industry Revenue, Growth Factors, Future Strategic Planning, Key Vendors, Market Contribution and DevelopmentsGlobal Phenobarbital Market and Ribavirin Market Outlook to 2027 By Upcoming Trends and Challenges, Industry Revenue, Growth Factors, Future Strategic Planning, Key Vendors, Market Contribution and Developments
feeds.benzinga.com - February 15 at 6:58 AM
Eli Lilly and (NYSE:LLY) PT Raised to $235.00 at CowenEli Lilly and (NYSE:LLY) PT Raised to $235.00 at Cowen
americanbankingnews.com - February 12 at 10:08 AM
Lilly To Participate in SVB Leerink Global Healthcare ConferenceLilly To Participate in SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 11 at 6:39 PM
Thinking about trading options or stock in Coca-Cola, Eli Lilly, Baidu, Canopy Growth Corp, or Match Group?Thinking about trading options or stock in Coca-Cola, Eli Lilly, Baidu, Canopy Growth Corp, or Match Group?
marketwatch.com - February 10 at 7:27 PM
FDA greenlights Eli Lilly COVID-19 combo therapyFDA greenlights Eli Lilly COVID-19 combo therapy
msn.com - February 10 at 2:26 PM
FDA issues emergency use authorization for Eli Lillys COVID-19 antibody comboFDA issues emergency use authorization for Eli Lilly's COVID-19 antibody combo
msn.com - February 10 at 9:26 AM
Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for UseCovid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use
wsj.com - February 10 at 9:26 AM
Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19
finance.yahoo.com - February 10 at 9:26 AM
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency ApprovalEli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
finance.yahoo.com - February 10 at 9:26 AM
FDA grants authorization to Lillys COVID-19 antibody treatmentFDA grants authorization to Lilly's COVID-19 antibody treatment
finance.yahoo.com - February 10 at 9:26 AM
Eli Lillys antibody combination receives FDA emergency use authorization for COVID-19Eli Lilly's antibody combination receives FDA emergency use authorization for COVID-19
msn.com - February 10 at 12:15 AM
Lilly says CFO resigns after investigation into inappropriate relationshipLilly says CFO resigns after investigation into inappropriate relationship
reuters.com - February 9 at 7:15 PM
Eli Lilly CFO resigns after inappropriate communications with employeesEli Lilly CFO resigns after 'inappropriate' communications with employees
msn.com - February 9 at 2:14 PM
Eli Lilly CFO resigns amid allegations of inappropriate employee relationshipEli Lilly CFO resigns amid allegations of 'inappropriate' employee relationship
msn.com - February 9 at 2:14 PM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.